Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF713 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | ZNF720 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF746 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | ZNF764 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZNF775 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | ZNF804A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |